Dr. Ravi K. Duggirala, MD

Dr. Duggirala practices at Mease Countryside Hospital in Clearwater, Florida.

Dr. Duggirala's NPI, 1275607392, was assigned on November 20, 2006. Dr. Duggirala graduated from Kakatiya Medical College NTR in 1982. Dr. Duggirala holds Florida license ME96396.

Dr. Duggirala's primary practice is Mease Countryside Hospital, at 3231 N McMullen Booth Rd, Clearwater, FL 33761 in Pinellas County. The practice phone is (727) 725-6111.

Dr. Duggirala's primary practice is Mease Countryside Hospital in Clearwater, Florida. Dr. Duggirala is also affiliated with BayCare Mease Countryside Hospital. The medical group on file is Digestive Disease & Cancer Institute. Dmand AI also links Dr. Duggirala to 2 more hospitals, 1 physician office, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Duggirala practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Duggirala's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Duggirala is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Duggirala's licenses on file in 2 states: Florida and Texas.

Dmand AI lists acute diabetes, acute respiratory failure, arthritis, bile duct problems, cardiac arrhythmia, cellulitis, chronic hypertension and chronic kidney disease among the conditions Dr. Duggirala treats.

CMS data shows 1,135 Medicare services from Dr. Duggirala across 9 procedure codes in 2024, for 183 Medicare patients. Medicare paid $104,045 for them.

CMS counts 183 Medicare patients who saw Dr. Duggirala in 2024. The largest group is 75 to 84, with 75 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Duggirala's median patient age at 80, with 53% women.

In 2024, Dr. Duggirala wrote 5,306 Medicare Part D claims for 723 patients. 88% of them were for generic drugs. CMS names the drug for 4,550 of them, across 89 drugs with 11 or more claims each, at $199,036 in total drug cost. In 2023, CMS named 5,364 claims across 102 drugs.

Dr. Duggirala accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 53 papers to Dr. Duggirala, published from 2000 to 2023. 2014 was the busiest year, with 5. The most frequent topics are Genetic Predisposition to Disease, Mexican Americans and Genetic Linkage. Dr. Duggirala has published most often in Genet Epidemiol. Dr. Duggirala's most frequent co-authors are Rene L. Olvera, MD, Peter T. Fox, MD and Paul M. Thompson, MD.

CMS Open Payments shows 11 general payments to Dr. Duggirala from 7 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 96% of the total. Sunovion Pharmaceuticals Inc. paid the most, $75.

Dmand AI lists 1 award for Dr. Duggirala, most recently CMS Stage 1 EHR in 2013.

Dr. Duggirala graduated from Kakatiya Medical College NTR in 1982.

Dr. Duggirala is in network with 17 carriers, including Excellus BlueCross BlueShield, Elevance and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.